Androgen Receptor Assay with [<sup>3</sup>H]Methyltrienolone (R1881) in the Presence of Progesterone Receptors*
Endocrinology, Apr 1, 1979
The synthetic radiolabeled androgen methyltrienolone-17βhiydroxy-17α-methyl-estra-4,9,ll-trien-3-... more The synthetic radiolabeled androgen methyltrienolone-17βhiydroxy-17α-methyl-estra-4,9,ll-trien-3-one (R1881) is superior to the native ligand 5α-dihydrotestosterone (DHT) in the measurement of androgen receptor (AR), especially in tissues where radiolabeled DHT binds with high affinity to plasma proteins in addition to receptor or is rapidly metabolized to inactive derivatives. However, R1881 also binds progesterone receptor (PgR), as shown by its ability to complete for [3]-promestone-17α,21-dimethyl-19-nor-pregna-4,9-diene-3,20-dione (R5020) binding to 8S PgR on sucrose density gradients, resulting in an overestimation of AR if PgR is present. Therefore, we have devised a method by which PgR binding of R1881 can be blocked without interfering with AR binding. The glucocorticoid triamcinolone acetonide (TA) was found to bind PgR (competition for 8S [3]R5020 binding) but not AR (no competition for 8S [3H]DHT binding). In cytosols containing both receptors, a 500-fold excess of unlabeled TA was sufficient ...
Uploads
Papers by David Zava